Athyrium Capital Management, LP is a specialized asset management company formed in 2008 to focus on investment opportunities in the global healthcare sector. Athyrium invests across all healthcare verticals including biopharma, medical devices and products, and healthcare services. Athyrium advises funds with over $1.7 billion of committed capital. Our investors consist of public and corporate pension funds, charitable endowments, insurance companies, funds-of-funds, family offices, university endowments, sovereign wealth funds, royalties, structured credit, and equities as well as select special situations.
Public regulatory records matched to Athyrium Capital Management from SEC and IRS filings.
Public filings matched to Athyrium Capital Management across SEC, IRS, DOL and international registers — newest first.
Cross-referenced from the LPbacked Signal Feed.
Browse more asset managers and other institutional investors by location and type in the LPbacked limited-partner database.
Athyrium Capital Management is a asset manager based in New York, United States, managing approximately $3.7B in assets.
Athyrium Capital Management is headquartered in New York, United States.
Athyrium Capital Management manages approximately $3.7B in assets under management.
Athyrium Capital Management focuses on Direct Investing, Philanthropy, Private Equity, Structured Equity, Biomedical Technology & Medical Research, Charitable Investments, Conservative Allocation, Endowment Fund.
Verified contact details, key decision-makers, and investment preferences for Athyrium Capital Management are available on LPbacked. Create a free account to access them.